粤公网安备 44011302004783号 Exclusive device
投放时间: 2025-07-18 08:00:00
Claim Your 60-day Free Trial Through Our Exclusive Physician Access Program.
Don’t miss out on AI-driven skin cancer detection—see beyond the surface with DermaSensor. For the first time in the U.S., physicians in family practice, internal medicine, concierge practices, and other non-dermatological clinics can assess lesions real-time for skin cancer risk using non-invasive technology.
As America’s first FDA-cleared, automated skin cancer detection device, DermaSensor is trusted by physicians near you.
Complete the form now to start your 60-day free trial through our exclusive Physician Access Program. See what others can't.
搜索关键词 AI skin cancer detection, non-invasive technology, DermaSensor free trial, FDA-cleared device, real-time lesion assessment, physician access program, skin cancer risk, automated skin cancer detection, medical diagnostic tool, early cancer detection优势 AI-driven skin cancer detection,Non-invasive technology,FDA-cleared,Real-time lesion assessment,60-day free trial
展示估值
77950
热度
7177
最新发现时间
2025-07-18 08:00:00
投放天数
210
素材信息
素材类型
素材尺寸
主页ID8289873642118573948
主页名字DermaSensor
产品信息
适用范围
人民币汇率走势
CNY
关注我们
新媒网跨境发布
本站原创内容版权归作者及NMedia共同所有，未经许可，禁止以任何形式转载。